Trial intelligence / Profile preview

Lodotra vs Prednisone IR in Polymyalgia Rheumatica

NCT01821040Phase 3Terminated

Sponsor
Mundipharma
Start
Mar 2013
Primary completion
Apr 2014
Countries
1
01

Overview

A Phase 3 trial of prednisone in polymyalgia rheumatica (PMR), sponsored by Mundipharma. Started Mar 2013; status: terminated.

02

Drugs

prednisone
03

Conditions

polymyalgia rheumatica (PMR)

Beyond the preview

Go deeper on NCT01821040.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01821040.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call